Tolerability & Safety of An Infant Formula

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate an extensively hydrolyzed formula in infants with cow's milk allergy.

n/a

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver)

See also
Status	Clinical Trial	Phase
Completed	`NCT02569840` - Amino Acid Feed Children's Study	N/A
Completed	`NCT00792090` - Prevention of Cow's Milk Allergy in Children	N/A
Completed	`NCT04893330` - Interest of Peticate Syneo Infant Formula in Children Allergic to Cow's Milk Protein: Real Life Study
Completed	`NCT01162473` - Milk Oral Immunotherapy in Children to Treat Food Allergy	Phase 0
Completed	`NCT00578656` - An Interventional Study of Milk Allergy	Phase 0
Completed	`NCT00356174` - An Observational Study of Childhood Food Allergy	N/A
Completed	`NCT00778258` - Study of Milk Allergy and Tolerance in Children	Phase 2
Completed	`NCT00465569` - A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy	Phase 1/Phase 2
Completed	`NCT01998074` - Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy	N/A